Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1451 to 1475 of about 5865

Previous 25

Website Changes

05/01/2017

Musella Foundation Copay Assistance Program reopens!

05/01/2017

Brain Tumor BioTech Conference June 2, 2017 in NY

04/26/2017

TARGETED THERAPY BEING TESTED IN SOCAL GIVES BRAIN CANCER PATIENTS HOPE

04/26/2017

Surgical success in previously “inoperable” brain cancers

04/26/2017

New Tupperware Fundraiser!

04/22/2017

Brains Matter Awareness Fundraiser and Celebration Luncheon / Now Accepting Nomination for our 2017 National Hope Award

04/21/2017

Pediatric Brain Tumor Mutations are Detectable in Cerebrospinal Fluid

04/20/2017

VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigating VB-111 in rGBM

04/19/2017

Effect of gross total resection (GTR) in WHO grade II astrocytomas: A SEER based survival analysis.

04/19/2017

Cloud Over Pediatric Oncologist and Brain Cancer Vaccine

04/18/2017

FDA Okays Clinical Trial of Injectable Brain Cancer Drug - See more at: https://www.specialtypharmacytimes.com/news/fda-okays-clinical-trial-of-injectable-brain-cancer-drug

04/17/2017

CNS Oncology Publishes Data Suggesting Survival Benefit of Optune™ in Combination with Second Line Chemotherapies after Glioblastoma Recurrence

04/17/2017

Survey on the use of animals in brain cancer research

04/14/2017

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

04/14/2017

Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial

04/12/2017

Feinstein Institute examines use of antiparasitic drug as new treatment for brain tumors

04/09/2017

DFFN: Phase 3 Trial of TSC in GBM to Initiate in 2017

04/07/2017

A Proposed New FDA Drug Approval Pathway: “Conditional Approval”

04/06/2017

Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

04/06/2017

Tocagen wins "Most Successful Early Phase Trial" and "Excellence in Rare Disease Drug Development" awards!

04/06/2017

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

04/05/2017

Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma

04/05/2017

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

04/03/2017

"Sci-fi" cancer therapy fights brain tumors, study finds

03/29/2017

MGH/Dana Farber Initiate Expansion of ONC201 Glioblastoma Trial

Our privacy / cookie policy has changed.
Click HERE to read it!